Bone Marrow TransplantationHematopoietic Stem Cell TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsStem Cell TransplantationTransplantation, AutologousGraft vs Host DiseaseTransplantation ConditioningBone and BonesStem CellsWhole-Body IrradiationHematopoietic Stem CellsLiver TransplantationPeripheral Blood Stem Cell TransplantationTransplantation ChimeraTissue DonorsGraft SurvivalLeukemiaHematologic NeoplasmsBusulfanAnemia, AplasticHistocompatibility TestingTreatment OutcomeBone Marrow PurgingKidney TransplantationBone Marrow DiseasesHistocompatibilityCombined Modality TherapyRecurrenceCyclophosphamideHematopoiesisTransplantation, IsogeneicRemission InductionTime FactorsBone Marrow ExaminationImmunosuppressive AgentsMice, Inbred C57BLLeukemia, Myeloid, AcuteCell DifferentiationBone RemodelingMesenchymal Stem Cell TransplantationRetrospective StudiesCord Blood Stem Cell TransplantationBone Marrow NeoplasmsMultiple MyelomaCell TransplantationSurvival AnalysisLeukemia, Myelogenous, Chronic, BCR-ABL PositiveGraft RejectionTransplantation ImmunologyHepatic Veno-Occlusive DiseasePrecursor Cell Lymphoblastic Leukemia-LymphomaHeart TransplantationAntineoplastic Combined Chemotherapy ProtocolsRadiation ChimeraMelphalanSurvival RateMyelodysplastic SyndromesLymphoma, Non-HodgkinImmunosuppressionDisease-Free SurvivalFlow CytometryLymphocyte DepletionGraft vs Leukemia EffectColony-Forming Units AssayAntigens, CD34Lung TransplantationHematologic DiseasesLeukemia, MyeloidHLA AntigensAcute DiseaseCells, CulturedT-LymphocytesFollow-Up StudiesMyeloablative AgonistsBone DensityHematopoietic Stem Cell MobilizationLymphocyte TransfusionGranulocyte Colony-Stimulating FactorGraft vs Tumor EffectOrgan TransplantationSevere Combined ImmunodeficiencyCell ProliferationPrognosisEmbryonic Stem CellsCytarabineCyclosporineBone ResorptionCytomegalovirus InfectionsChimerismChimeraLeukocyte TransfusionEtoposideAntineoplastic AgentsCarmustineGraft vs Host ReactionMesenchymal Stromal CellsAdult Stem CellsMice, Inbred BALB C